TT
Tempo Therapeutics, Inc.
SEC filingBiotechnology · San Diego, CA
Amount raised$14Msold at filing
Total offering$14.5M$500K still open
Investors in the raise43count reported to the SEC
FiledSep 11, 2026first sale Aug 27, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Donald GriffinDirector
Eric RichmanExecutive Officer, Director
Steven SandsDirector
Westbrook WeaverExecutive Officer, Director
Biren MehtaDirector
Executive officers, directors and promoters as listed on the Form D.